rebeccamycin has been researched along with camptothecin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anizon, F; Aubertin, AM; Bailly, C; Fabbro, D; Goossens, JF; Hénichart, JP; Labourier, E; Meyer, T; Moreau, P; Prudhomme, M; Riou, JF; Sancelme, M; Sevère, D; Tazzi, J | 1 |
| Bailly, C; Colson, P; Houssier, C; Prudhomme, M; Riou, JF; Rodrigues-Pereira, E | 1 |
| Bailly, C; Carrasco, C; Hamy, F; Prudhomme, M; Rubin, E; Saleem, A; Vezin, H | 1 |
| Bailly, C; Bjornsti, MA; Marcos, AR; Vance, JR; Woo, MH | 1 |
4 other study(ies) available for rebeccamycin and camptothecin
| Article | Year |
|---|---|
Synthesis, mode of action, and biological activities of rebeccamycin bromo derivatives.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Antineoplastic Agents; Bacillus cereus; Carbazoles; Cattle; DNA; DNA Topoisomerases, Type I; Enzyme Inhibitors; Glucose; Indoles; Inhibitory Concentration 50; Phosphotransferases; Protein Kinase C; Structure-Activity Relationship; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1999 |
DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Binding Sites; Camptothecin; Carbazoles; Cattle; Circular Dichroism; DNA; DNA Footprinting; DNA Restriction Enzymes; DNA Topoisomerases, Type I; Electrophoresis, Polyacrylamide Gel; Indoles; Intercalating Agents; Molecular Structure; Structure-Activity Relationship; Thymus Gland; Topoisomerase I Inhibitors | 1997 |
The camptothecin-resistant topoisomerase I mutant F361S is cross-resistant to antitumor rebeccamycin derivatives. A model for topoisomerase I inhibition by indolocarbazoles.
Topics: Amino Acid Substitution; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Base Sequence; Binding Sites; Camptothecin; Carbazoles; DNA Damage; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Enzyme Inhibitors; Glucosides; Humans; Indoles; Intercalating Agents; Models, Molecular; Molecular Sequence Data; Mutagenesis, Site-Directed; Phenylalanine; Recombinant Proteins; Serine; Topoisomerase I Inhibitors | 1999 |
Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Base Sequence; Binding Sites; Camptothecin; Carbazoles; DNA Primers; DNA Topoisomerases, Type I; Enzyme Inhibitors; Humans; Indoles; Mutagenesis; Mutation; Recombinant Proteins; Saccharomyces cerevisiae; Topoisomerase I Inhibitors | 2002 |